Drug Shortage Report for JAMP-LOSARTAN HCTZ
Report ID | 23908 |
Drug Identification Number | 02408244 |
Brand name | JAMP-LOSARTAN HCTZ |
Common or Proper name | Losartan HCTZ |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-09-01 |
Estimated end date | |
Actual end date | 2018-05-18 |
Shortage status | Resolved |
Updated date | 2018-05-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.